Comorbidities and Coexisting Conditions
77
19
26
31
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.3%
1 terminated out of 77 trials
96.9%
+10.3% vs benchmark
1%
1 trials in Phase 3/4
3%
1 of 31 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 31 completed trials
Clinical Trials (77)
Family-Based Treatment for Type 1 Diabetes
eCardiacRehab - a Hybrid Patient-Centered eHealth Programme
Evaluating Smoking Cessation Interventions for PWH in South Africa
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity
Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy
A4i-O: A Platform for Complex Behavioral Health to Address OUD
Exploring Multimorbidity in Patients With Spinal Pain
Comorbidity-Oriented Primary Care and Integrated Management for Hypertension and Diabetes Mellitus
Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.
An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM
Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients
The Danish Comorbidity in Liver Transplant Recipients Study
Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
REal-time Data Monitoring for Shared Adaptive, Multi-domain and Personalised Prediction and Decision Making for Long-term Pulmonary Care Ecosystems (RE-SAMPLE)
MDT Conferences for People With Diabetes and Multimorbidity
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
Comorbidity Management in Rheumatic Disease.
Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB)
Conversion to SADI-S, RYGB or OAGB After Failed Sleeve